JAAD Online
COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated

https://doi.org/10.1016/j.jaad.2022.02.070Get rights and content

Cited by (0)

Funding sources: None.

IRB approval status: Not applicable.

Key words: COVID-19 vaccination; immune-mediated inflammatory diseases; rituximab.

Reprints not available from the authors.

View Abstract